Prevalent bacterial species and novel phylotypes in advanced noma lesions

被引:99
作者
Paster, BJ
Falkler, WA
Enwonwu, CO
Idigbe, EO
Savage, KO
Levanos, VA
Tamer, MA
Ericson, RL
Lau, CN
Dewhirst, FE
机构
[1] Forsyth Inst, Dept Mol Genet, Boston, MA 02115 USA
[2] Harvard Univ, Sch Dent Med, Dept Oral Biol, Boston, MA 02115 USA
[3] Univ Maryland, Sch Dent, Dept Oral & Craniofacial Biol Sci, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Biochem, Baltimore, MD 21201 USA
[5] Nigerian Inst Med Res, Lagos, Nigeria
关键词
D O I
10.1128/JCM.40.6.2187-2191.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The purpose of this study was to determine the bacterial diversity in advanced noma lesions using culture-independent molecular methods. 16S ribosomal DNA bacterial genes from DNA isolated from advanced noma lesions of four Nigerian children were PCR amplified with universally conserved primers and spirochetal selective primers and cloned into Escherichia coli. Partial 16S rRNA sequences of approximately 500 bases from 212 cloned inserts were used initially to determine species identity or closest relatives by comparison with sequences of known species or phylotypes. Nearly complete sequences of approximately 1,500 bases were obtained for most of the potentially novel species. A total of 67 bacterial species or phylotypes were detected, 25 of which have not yet been grown in vitro. Nineteen of the species or phylotypes, including Propionibacterium acnes, Staphylococcus spp., and the opportunistic pathogens Stenotrophomonas maltophilia and Ochrobactrum anthropi were detected in more than one subject. Other known species that were detected included Achromobacter spp., Afipia spp., Brevundimonas diminuta, Capnocytophaga spp., Cardiobacterium sp., Eikenella corrodens, Fusobacterium spp., Gemella haemoylsans, and Neisseria spp. Phylotypes that were unique to noma infections included those in the genera Eubacterium, Flavobacterium, Kocuria, Microbacterium, and Porphyromonas and the related Streptococcus salivarius and genera Sphingomonas and Treponema. Since advanced noma lesions are infections open to the environment, it was not surprising to detect species not commonly associated with the oral cavity, e.g., from soil. Several species previously implicated as putative pathogens of noma, such as spirochetes and Fusobacterium spp., were detected in at least one subject. However, due to the limited number of available noma subjects, it was not possible at this time to associate specific species with the disease.
引用
收藏
页码:2187 / 2191
页数:5
相关论文
共 34 条
[1]   The need for action against oro-facial gangrene (noma) [J].
Barmes, DE ;
Enwonwu, CO ;
Leclercq, MH ;
Bourgeois, D ;
Falkler, WA .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 1997, 2 (12) :1111-1114
[2]   Molecular analysis of bacterial species associated with childhood caries [J].
Becker, MR ;
Paster, BJ ;
Leys, EJ ;
Moeschberger, ML ;
Kenyon, SG ;
Galvin, JL ;
Boches, SK ;
Dewhirst, FE ;
Griffen, AL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (03) :1001-1009
[3]   Infective endocarditis due to unusual or fastidious microorganisms [J].
Berbari, EF ;
Cockerill, FR ;
Steckelberg, JM .
MAYO CLINIC PROCEEDINGS, 1997, 72 (06) :532-542
[4]  
Beringer P M, 2000, Curr Opin Pulm Med, V6, P545, DOI 10.1097/00063198-200011000-00015
[5]  
Boches SK, 2000, J DENT RES, V79, P396
[6]   Noma: report of a case resulting in bony ankylosis of the maxilla and mandible [J].
Deeb, GR ;
Yih, WY ;
Merrill, RG ;
Lundeen, RC .
DENTOMAXILLOFACIAL RADIOLOGY, 1999, 28 (06) :378-382
[7]   The diversity of periodontal spirochetes by 16S rRNA analysis [J].
Dewhirst, FE ;
Tamer, MA ;
Ericson, RE ;
Lau, CN ;
Levanos, VA ;
Boches, SK ;
Galvin, JL ;
Paster, BJ .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 2000, 15 (03) :196-202
[8]   Pathogenesis of cancrum oris (noma): Confounding interactions of malnutrition with infection [J].
Enwonwu, CO ;
Falkler, WA ;
Idigbe, EO ;
Afolabi, BM ;
Ibrahim, M ;
Onwujekwe, D ;
Savage, O ;
Meeks, VI .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1999, 60 (02) :223-232
[9]  
ENWONWU CO, 1995, B WORLD HEALTH ORGAN, V73, P541
[10]  
Falkler WA, 1999, ORAL DIS, V5, P150